Products for Research Use Only
RegisterLogin

Enasidenib

CAT: 0804-HY-18690-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18690-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.
CAS Number
1446502-11-9
Product Name Alternative
AG-221
UNSPSC
12352005
Hazard Statement
H302, H320
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Enasidenib.html
Purity
99.97
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1
Molecular Formula
C19H17F6N7O
Molecular Weight
473.38
Precautions
H302, H320
References & Citations
[1]Exploring the Pathway: IDH Mutations and Metabolic Dysregulation in Cancer Cells: A Novel Therapeutic Target. MAY 29, 2015|[2]Alan H. Shih, et al. AG-221, a Small Molecule Mutant IDH2 Inhibitor, Remodels the Epigenetic State of IDH2-Mutant Cells and Induces Alterations in Self-Renewal/Differentiation in IDH2-Mutant AML Model in Vivo. Blood 2014 124:437.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
IDH2

Alternative Products

CatalogName
TRC-E555360-10MGEnasidenib
MBS5773330Enasidenib mesylate
CS-EO-02982Enasidenib d6
A15808-50Enasidenib 50mg
A15808-10Enasidenib 10mg
A15808-5Enasidenib 5mg
A15808-25Enasidenib 25mg
A15808-500Enasidenib 500mg
A15808-200Enasidenib 200mg
A15808-100Enasidenib 100mg

Popular Products